Nihan Erginel-Unaltuna

Nihan Erginel-Unaltuna

Auto-generated profile, based on publicly available information

Nihan Erginel-Unaltuna

Department of Genetics, Aziz Sancar Institute of Experimental Medicine, Istanbul University, Istanbul, Turkey

Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2016 in The American Journal of Human Genetics
Verified
Journal Article
Closed access
SLSuzanne Lesage
Suzanne Lesage
VDValérie Drouet
Valérie Drouet
EMElisa Majounie
Elisa Majounie
VDVincent Deramecourt
Vincent Deramecourt
MJMaxime Jacoupy
Maxime Jacoupy
ASAndrew B. Singleton
Andrew B. Singleton

1 January 2009 in Annals of Medicine
Verified
Journal Article
Closed access
NONiku Oksala
Niku Oksala
MLMari Levula
Mari Levula
NANina Airla
Nina Airla
MPMarkku Pelto-Huikko
Markku Pelto-Huikko
RORebekka M. Ortiz
Rebekka M. Ortiz
TLTerho Lehtimäki
Terho Lehtimäki
Background and aims. The expression of disintegrin and metalloprotease ADAM-9, ADAM-15, and ADAM-17 has been associated with cell-cell, cell-platelet, and cell-matrix interactions and inflammation. They are possibly implicated in the pathophysiology of atherosclerosis. Methods and results. Whole-genome expression array and quantitative real-time polymerase chain reaction (PCR) analysis confirmed that ADAM-9, ADAM-15, and ADAM-17 are upregulated in advanced human atherosclerotic lesions in samples from carotid, aortic, and femoral territories compared to samples from internal thoracic artery (ITA) free of atherosclerotic plaques. Western analysis indicated that the majority of these ADAMs were in the catalytically active form. ADAM-9, ADAM-15, and ADAM-17-expressing cells were shown to co-localize with CD68-positive cells of monocytic origin in the atherosclerotic plaques using immunohistochemistry and double-staining immunofluorescence analysis. Co-localization was demonstrated in all vascular territories. In the carotid territory, cells expressing the ADAMs co-distributed also with smooth muscle cells and, in femoral territory, with CD31-positive endothelial cells, indicating that the ADAM expression pattern depends on vascular bed territory. Conclusions. Present findings provide strong evidence for the involvement of catalytically active ADAM-9, ADAM-15, and ADAM-17 in advanced atherosclerosis, most notably associated with cells of monocytic origin.

23 May 2015 in Movement Disorders
Verified
Journal Article
Closed access
PDF file
ELEbba Lohmann
Ebba Lohmann
ACAnne‐Sophie Coquel
Anne‐Sophie Coquel
AHAurélie Honoré
Aurélie Honoré
HGHakan Gürvit
Hakan Gürvit
HHHasmet Hanagasi
Hasmet Hanagasi
ABAlexis Brice
Alexis Brice

1 December 2003 in Respiratory Medicine
Verified
Journal Article
Closed access
PYPinar Yildiz
Pinar Yildiz
HOHuseyin Oflaz
Huseyin Oflaz
NCNaci Cine
Naci Cine
NENihan Erginel-Ünaltuna
Nihan Erginel-Ünaltuna
FEFaruk Erzengin
Faruk Erzengin
VYVeysel Yilmaz
Veysel Yilmaz

1 August 2012 in Neurobiology of Aging
Verified
Journal Article
Closed access
ELEbba Lohmann
Ebba Lohmann
RGRita Guerreiro
Rita Guerreiro
NENihan Erginel-Unaltuna
Nihan Erginel-Unaltuna
NGNicole Gurunlian
Nicole Gurunlian
BBBasar Bilgic
Basar Bilgic
ASAndrew Singleton
Andrew Singleton

1 January 2004 in Journal of Asthma
Verified
Journal Article
Closed access
PYPinar Yildiz
Pinar Yildiz
HOHuseyin Oflaz
Huseyin Oflaz
NCNaci Cine
Naci Cine
HGHakan Genchallac
Hakan Genchallac
NENihan Erginel‐Ünaltuna
Nihan Erginel‐Ünaltuna
VYVeysel Yilmaz
Veysel Yilmaz
Objectives. Polymorphisms of the angiotensin converting enzyme (ACE) and endothelial nitric oxide (eNOS) genes have been implicated in asthma pathogenesis. Angiotensin II and NO have important roles in maintaining vascular tone. In this study, the relationship between endothelial dysfunction and ACE and eNOS gene polymorphisms was investigated in patients with asthma. Methods. This cross‐sectional, controlled study was conducted at the Yedikule Chest Disease Hospital and Cardiology Center in a University Hospital. Forty‐nine patients with asthma (18 male, 31 female; mean age: 33 ± 12 years) and 49 age‐ and sex‐matched healthy controls (20 male, 29 female; mean age: 30 ± 8 years) were included. Pulmonary function tests and flow‐mediated dilatation of the brachial artery [endothelium dependent dilatation (EDD)] were examined by high‐resolution ultrasonography. The ACE and eNOS genotypes were determined by PCR. Results. Asthma patients showed lower EDD (12 ± 6% vs. 22 ± 6%, p < 0.001) as compared to controls...